International Osteoporosis Foundation

Global Osteoporosis Drugs Market Outlook to 2023 with Market Positioning of Vendors - Amgen, Eli Lilly & Company, Novartis, Pfizer, and Radius Health - ResearchAndMarkets.com

Retrieved on: 
Monday, April 8, 2019
Health, Pharmaceutical, Managed care, Osteopathies, Osteoporosis, RTT, Health, International Osteoporosis Foundation, Royal Osteoporosis Society

The "Global Osteoporosis Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Osteoporosis Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
  • The osteoporosis drugs market will register a CAGR of almost 5% by 2023.
  • The availability of reimbursement programs for patients with osteoporosis will drive the market growth during the forecast period.
  • Osteoporosis prevalence has increased worldwide due to which it is considered a serious public health concern.

The National Osteoporosis Foundation Adds to Its Mission Department

Retrieved on: 
Wednesday, November 7, 2018
Anatomy, Osteopathies, Skeletal system, Osteoporosis, RTT, Bone, World Osteoporosis Day, International Osteoporosis Foundation

ARLINGTON, Va., Nov. 7, 2018 /PRNewswire/ --The National Osteoporosis Foundation (NOF), the nation's leading health organization solely dedicated to osteoporosis and bone health, announced the addition of two thoughtful new leaders to its newly designated Mission department, underscoring the organization's commitment to delivering quality educational programming for patients and healthcare professionals.

Key Points: 
  • ARLINGTON, Va., Nov. 7, 2018 /PRNewswire/ --The National Osteoporosis Foundation (NOF), the nation's leading health organization solely dedicated to osteoporosis and bone health, announced the addition of two thoughtful new leaders to its newly designated Mission department, underscoring the organization's commitment to delivering quality educational programming for patients and healthcare professionals.
  • She will also help to develop and launch a Patient Reported Outcomes Database (new and the first of its kind for osteoporosis).
  • Established in 1984, the National Osteoporosis Foundation is the nation's leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of awareness, education, advocacy and research.
  • For more information on the National Osteoporosis Foundation, visit www.nof.org .

Don't Miss the Signs of a Breaking Spine, Warns IOF

Retrieved on: 
Friday, October 19, 2018
Medical Subject Headings, Bone fractures, Medical classification, Endocrine diseases, Health, International Osteoporosis Foundation, RTT, Osteoporosis, Back pain, Vertebral compression fracture, Pregnancy and lactation-associated osteoporosis

Spine (or 'vertebral') fractures are the most common osteoporotic fractures - with one new fracture estimated to occur every 22 seconds worldwide.

Key Points: 
  • Spine (or 'vertebral') fractures are the most common osteoporotic fractures - with one new fracture estimated to occur every 22 seconds worldwide.
  • IOF President, Professor Cyrus Cooper, stated: "Patients with sudden back pain are often simply prescribed pain killers and not properly assessed and treated for the underlying cause.
  • Together with its 240-member organizations worldwide, IOF calls on health care professionals to address the under-reporting and under-treatment of spine fractures.
  • http://www.worldosteoporosisday.org #WorldOsteoporosisDay
    The International Osteoporosis Foundation (IOF) is the world's leading NGO dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases:

Europe Osteoporosis Market Forecast 2018-2026: Key Opportunities & Challenges

Retrieved on: 
Friday, July 13, 2018
Osteopathies, Aging-associated diseases, Endocrine diseases, Osteoporosis, RTT, Health, International Osteoporosis Foundation

The research provides insights into Osteoporosis epidemiology, Osteoporosis diagnosed patients, and Osteoporosis treatment rate for EU5 countries.

Key Points: 
  • The research provides insights into Osteoporosis epidemiology, Osteoporosis diagnosed patients, and Osteoporosis treatment rate for EU5 countries.
  • The research measures key indicators including prevalence of Osteoporosis derived from epidemiological analysis, patients diagnosed with Osteoporosis, and patients treated with a drug therapy.
  • The research study helps executives estimate Osteoporosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks.
  • The research provides estimates and forecasts of Osteoporosis prevalence, Osteoporosis diagnosis rate, and Osteoporosis treatment rate for the period 2017-2026.

HSS Researchers Launch Study to Measure Bone Effects of New Rheumatologic Agent

Retrieved on: 
Monday, May 7, 2018
Anatomy, Osteopathies, Osteoporosis, RTT, International Osteoporosis Foundation, Bone, Medication-associated osteonecrosis of the jaw, National Osteoporosis Society

Despite the overactive growth of bone, people with SpA often suffer from osteoporosis, a condition marked by fragile skeletons vulnerable to fracture.

Key Points: 
  • Despite the overactive growth of bone, people with SpA often suffer from osteoporosis, a condition marked by fragile skeletons vulnerable to fracture.
  • Osteoporosis and low bone mass affect an estimated 44 million men and women in the United States, according to the International Osteoporosis Foundation.
  • The study, "The Effects of Secukinumab on Bone Health and Metabolism," is now enrolling patients.
  • The HSS Education Institute provides continuing medical curriculum to more than 15,000 subscribing musculoskeletal healthcare professionals in 110 countries.

Global Osteoporosis Epidemiology and Patient Flow Report 2018

Retrieved on: 
Tuesday, April 17, 2018
Osteopathies, Osteoporosis, RTT, Anatomy, Health, International Osteoporosis Foundation, Medicine

The "Global Osteoporosis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Osteoporosis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
  • The research provides insights into Osteoporosis epidemiology, Osteoporosis diagnosed patients, and Osteoporosis treatment rate for US, Japan, and EU5 countries.
  • The research measures key indicators including prevalence of Osteoporosis derived from epidemiological analysis, patients diagnosed with Osteoporosis, and patients treated with a drug therapy.
  • The research provides estimates and forecasts of Osteoporosis prevalence, Osteoporosis diagnosis rate, and Osteoporosis treatment rate for the period 2017 - 2026.